India healthcare investment Q3 2026 graphic showing 3.1 billion dollars

India healthcare investment Q3 2026 reached $3.1 billion in private-equity and venture-capital deals, making healthcare the second-largest sector after infrastructure, according to the EY-IVCA report published on 30 October 2026. Across all sectors, PE/VC investment totalled $17.1 billion over 348 deals, up 46% in value from a year earlier. The largest deal of the quarter was KKR’s agreed acquisition of Medicover India for about $1.4 billion. This explainer sets out the numbers, the healthcare deals behind them and the limits of the data. It is news reporting and not investment advice.

India healthcare investment Q3 2026: key takeaways

  • Healthcare drew $3.1 billion, second to infrastructure at $7.2 billion; real estate was third at $1.4 billion.
  • By our own calculation, healthcare was about 18% of the $17.1 billion total.
  • Total PE/VC value rose 46% year on year, but the number of deals fell 9% from 384 to 348, so the growth came from larger cheques.
  • KKR’s Medicover India deal, about $1.4 billion, was the largest of the quarter.
  • EY expects investors to remain cautious and selective going forward.

What the EY-IVCA report says about India healthcare investment Q3 2026

The EY-IVCA release for the third quarter of 2026 reports $17.1 billion across 348 deals, up from $11.7 billion a year earlier and up 124% from $7.6 billion in the second quarter. Infrastructure, healthcare and real estate together took 69% of the total. Large deals, 36 of them, accounted for $13 billion, or 76% of the quarter’s value. The Indian Private Equity and Venture Capital Association is the industry body that co-publishes the report.

Larger cheques behind India healthcare investment Q3 2026

Buyouts were the largest deal type at $5.1 billion, up from $1 billion a year earlier, while start-up investment was $4.8 billion and growth deals were $3.5 billion. By our own calculation, the $1.4 billion Medicover India deal equals about 27% of buyout value and about 8% of all investment in the quarter. That concentration matters: a single transaction can swing a sector total, so healthcare’s second place owes much to hospital deals. The report does not give a deal count for healthcare alone.

The hospital deals inside India healthcare investment Q3 2026

Secondary reports on the data say hospital systems drew about $1.8 billion, the largest share of private equity going into Indian healthcare. We could not confirm this split in the EY release itself, so treat it as reported and not verified. The same reports describe three transactions.

  • KKR and Medicover India: reported enterprise value of about €1.2 billion for a network of 24 hospitals and about 4,800 beds across South and West India, with closing expected in the fourth quarter of 2026. Visit KKR for the firm’s own information.
  • Advent International and Yatharth Hospitals: a reported ₹3,150 crore for close to a quarter of the chain on 17 September, at about 33 times EBITDA against an average of about 27 times for listed hospital chains, according to those reports.
  • Baby Memorial and Star Hospitals: a reported agreement for a controlling stake in the Hyderabad-based hospital.

The valuation multiples are the reports’ figures and we have not recalculated them.

Exits and listings in India healthcare investment Q3 2026

Healthcare exits totalled $1.4 billion, third among sectors after financial services at $2.8 billion and e-commerce at $2 billion. Across all sectors, exits were $10.4 billion over 113 deals, down 24% in value from last year but up 107% from the previous quarter. PE-backed IPOs numbered 27, the most in any quarter, yet raised only $1.2 billion. Since 2021, healthcare ranks fifth by IPO exit value.

What India healthcare investment Q3 2026 means for hospitals and patients

Investors tend to favour hospital chains with clear bed expansion plans and specialist platforms. For patients, new owners can bring capital for beds and equipment, and critics point to pricing pressure on bills; the data here cannot show either effect. For hospitals, high valuations make acquisitions costly but also make listings attractive. Our coverage of billing rules is in our report on Karnataka’s price disclosure pause.

Market context from Acumen Research and Consulting

We did not find an Acumen report on Indian healthcare deals. A broad services report, Acumen Research and Consulting’s Ambulatory Health Care Services Market, values that global segment at USD 878.4 billion in 2024 and projects USD 1,390.3 billion by 2033, a CAGR of 5.3% for 2025 to 2033, with North America near USD 333.8 billion, about 38% by our own calculation, and Asia Pacific growing fastest at 5.9%. The stated endpoints imply a slightly lower rate of about 5.2%, and the page’s dates should be verified, so use the figures as indicative. The report covers outpatient services worldwide and not Indian hospitals.

Questions about India healthcare investment Q3 2026

Will the Medicover deal close on schedule? Do higher valuations lead to more listings? Will deal counts recover? The report does not answer these. See more in our healthcare services section.

Timeline of India healthcare investment Q3 2026

  • July to September 2026: the third quarter, with September the strongest month of 2026 at about $7 billion across all sectors.
  • 17 September 2026: Advent’s reported Yatharth Hospitals investment.
  • 30 October 2026: EY-IVCA report published.
  • Fourth quarter of 2026: Medicover India deal expected to close, per reports.

General background: how PE/VC data is compiled

EY and IVCA compile monthly roundups from public sources and deal databases. Totals can be revised later, and definitions such as large deal are not always spelled out. EY’s third-quarter 2025 deal count of 384 in the new release differs from the 369 in its original release, so the baseline may have been revised.

Our analysis of India healthcare investment Q3 2026

In our assessment, India healthcare investment Q3 2026 shows investors committing larger sums to fewer, hospital-led deals. Second place is real, but one quarter and one very large transaction are a thin base for calling a trend.

What is not disclosed about India healthcare investment Q3 2026

  • The number of healthcare deals in the quarter.
  • A verified hospital-versus-other split.
  • Regulatory approvals and final terms of the Medicover deal.

Risks and caveats

This article uses the EY-IVCA release and secondary reports of deal details. Percentages marked as ours are calculations. Deal values and multiples from secondary reports are unverified. This is not investment advice.

What to watch next

  • Completion of the Medicover transaction.
  • The fourth-quarter EY-IVCA report.
  • Hospital IPO filings.

FAQ

How much did healthcare attract in Q3 2026?

$3.1 billion, second after infrastructure, per EY-IVCA.

What was the largest deal?

KKR’s acquisition of Medicover India, about $1.4 billion.

Did the number of deals rise?

No. Deals fell 9% to 348 even as value rose 46%.

How we reported this: we relied on the EY-IVCA release of 30 October 2026, secondary reports of deal details, public pages and the Acumen Research and Consulting report cited above. Our calculations are labelled. Last updated 2 November 2026. This is news reporting and not advice.

By Simone Lamb

Simone Lamb is the editor of Medgadget.in, covering healthcare technology, medical devices, and the latest developments in digital health.

4 thoughts on “India Healthcare Attracts $3.1 Billion in PE/VC Investments in Q3 2026, EY-IVCA Reports”

Leave a Reply

Your email address will not be published. Required fields are marked *